Lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof
AssigneeGenMont Biotech Inc.
InventorsYing-Chen Leu, Feng-Ching Hsieh
Life of this patent
Estimating the term…
Abstract
The invention relates to a composition for improving the syndrome of diabetes and complication thereof. The composition comprises an effective amount of Lactobacillus strain which is at least one selected from the group consisting of: Lactobacillus reuteri GMNL-89 strain, Lactobacillus gasseri GMNL-205 strain, Lactobacillus reuteri GMNL-263 strain and a pharmaceutical acceptable vehicle. The Lactobacillus gasseri GMNL-205 strain and Lactobacillus reuteri GMNL-263 strain are novel isolated Lactobacillus strains. In addition, the invention also relates to a novel use of the composition or the Lactobacillus strains for improving the syndrome of diabetes and complication thereof.
Claims5
A composition for improving syndrome of diabetes and complication thereof, comprising an effective amount of Lactobacillus which is at least one selected from the group consisting of Lactobacillus reuteri GMNL-89, Lactobacillus gasseri GMNL-205, and Lactobacillus reuteri GMNL-263, and a pharmaceutically acceptable vehicle, wherein the deposition number of said Lactobacillus reuteri GMNL-89 is CCTCC M207154;
- the deposition number of said Lactobacillus gasseri GMNL-205 is CCTCC M209262;
- and the deposition number of said Lactobacillus reuteri GMNL-263 is CCTCC M209263.
A novel Lactobacillus isolated strain, which is a deposited strain selected from the following:
- 1. Lactobacillus gasseri GMNL-205, which is deposited CCTCC (China Center for Type Culture Collection), with deposition number of CCTCC M209262;
- and
- 2. Lactobacillus reuteri GMNL-263, which is deposited CCTCC (China Center for Type Culture Collection), with deposition number of CCTCC M209263.
Dependencies are inferred from the claim text.